Day: November 17, 2021

Sandusky, OH, Nov. 17, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry consultants and other pharmaceutical firms in an effort to explore various opportunities to accelerate and diversify development. As the in-depth review continues, PAOG has now identified derivate opportunities from its research to launch additional pharmaceutical product development projects.  The identified opportunities PAOG plans to pursue have fast-track potential and it now...

Company Continues Forward Momentum Following IPO, Expanded Product Portfolio and Increased Global Footprint FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced a significant milestone: the company has shipped 1,000 of its cell analysis systems. Since first being introduced in 2017, Cytek’s cell analysis systems have gained widespread adoption across the globe with use in more than 35 countries. Utilizing Cytek’s patented Full Spectrum Profiling™ (FSP™) technology, Cytek provides an integrated suite of solutions with its Aurora and Northern Lights™ systems, Aurora CS cell sorter, reagents, software and services. To provide researchers with a more comprehensive understanding of the human immune system, Cytek has broadened its product...

NEWPORT NEWS, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that Mike Aldinger has joined its Technical Solutions division as vice president of HII’s live, virtual, constructive (LVC) training solutions with a focus on growth and engagements with the U.S. Air Force. HII’s LVC training solutions team offers artificial intelligence-driven advanced simulation capabilities, including virtual and augmented reality and large, integrated exercises around the globe, to enable the U.S. Department of Defense to meet critical readiness requirements. “HII’s extensive portfolio of U.S. Air Force and U.S. Navy training has helped transform LVC across the joint defense community,” said Glenn Goodman, president of HII’s LVC Solutions business group. “Mike’s experience in tailoring and scaling mission...

BOSTON, Nov. 17, 2021 (GLOBE NEWSWIRE) — First Eagle Alternative Capital BDC, Inc. (NASDAQ: FCRD) (“First Eagle Alternative Capital BDC” or the “Company”) announced that it priced a public offering of an additional $40,000,000 aggregate principal amount of 5.00% Notes due 2026 (the “Notes”). The Notes will be issued at a price of approximately 101% of the aggregate principal amount of the Notes, resulting in a yield-to-maturity of approximately 4.75%. The Notes will mature on May 25, 2026 and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 25, 2023. The Notes will bear interest at a rate of 5.00% per year payable quarterly on March 30, June 30, September 30 and December 30 of each year. The Company also granted the underwriters a 30-day option to purchase up to an additional...

NEW YORK, Nov. 17, 2021 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today the launch of a public offering of its Series G Cumulative Redeemable Preferred Stock (the “Series G Preferred Stock”). The Company intends to list the Series G Preferred Stock on the Nasdaq Global Select Market under the symbol “NYMTZ.” The Company intends to grant the underwriters an option for 30 days to purchase additional shares of the Series G Preferred Stock to cover over-allotments, if any. Morgan Stanley, J.P. Morgan, UBS Investment Bank, Wells Fargo Securities and Keefe, Bruyette & Woods, A Stifel Company are acting as joint book-running managers for the offering. The Company intends to use the net proceeds of the offering to fund the redemption of up to all of the outstanding shares of its 7.75%...

$UVSS – Digital Distro Solutions, Inc.Digital Distro Solutions, Inc. – Digi Market$UVSS – Digital Distro Solutions, Inc.$UVSS Library of AssetsSHERIDAN, WY, Nov. 17, 2021 (GLOBE NEWSWIRE) — Universal Systems, Inc./Digital Distro Solutions, Inc. (OTC Pink: UVSS) proudly announces the company has achieved Pink Current status for OTC Markets. Mr. Andrew Lane, CEO of Universal Systems, Inc./Digital Distro, states, “Our team of internal staff, partners, attorneys, and executive leadership have constantly worked to ensure that all due diligence and transparency were provided and documented. I want to thank the team for their professional and persistent efforts to revive Universal System, Inc. into a now OTC Pink Current company. For the next two fiscal quarters, we will complete our...

Westport, CT, Nov. 17, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would participate in The Benchmark Company 10th Annual Discovery One on One Investor Conference (Virtual) on Thursday, December 2, 2021. The Company’s executive leadership will provide a business update on the roll-out of its FDA 510(k) cleared medical device, the PURE EP™ System, that aims to drive procedural efficiency and efficacy in cardiac electrophysiology and outline key priorities for the next phase of its commercial and clinical growth. To date, 73 physicians have completed over...

CHARLOTTESVILLE, Va., Nov. 17, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, reminds investors that it will host a conference call at 11:00 A.M. Eastern Time on Thursday, November 18, 2021 to provide a clinical update and discuss the latest business developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 856729. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2463/43766 or on the Company’s website at https://ir.adialpharma.com/. A webcast replay of the call will...

Not for distribution to United States newswire services or for dissemination in the United States ROUYN-NORANDA, Quebec, Nov. 17, 2021 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF) (“Radisson” or the “Corporation“) is pleased to announce that due to investor demand with its previously announced private placement, it has entered into an agreement with Eight Capital as lead agent and sole bookrunner, on behalf of a syndicate of agents (together the “Agents”) pursuant to which the Corporation and the agents have agreed to upsize the proposed private placement (the “Offering”) for aggregate gross proceeds of up to$ 6,000,000 of securities in any combination from the sale of Class A shares of the Corporation that qualify as “flow-through shares”: (i) Flow-through Class A shares of the Corporation at...

TORONTO, Nov. 17, 2021 (GLOBE NEWSWIRE) — Highmark Interactive Inc. (“Highmark” or the “Company”) is pleased to announce approval for trading on the TSX Venture Exchange (“TSXV”) under the symbol HMRK on November 17th, 2021. The listing follows the closing of the Company’s previously announced qualifying transaction, consisting of the acquisition of all of the issued and outstanding securities in the capital of Highmark Innovations Inc. as well as the concurrent closing of the acquisitions of Complex Injury Rehab Inc. and Highmark Health Mississauga. By fusing proprietary, digital clinical decision support technology with virtual and traditional models of health service, Highmark is committed to delivering better outcomes for people struggling with their brain or mental health. Dr. Sanjeev Sharma, CEO of Highmark, noted, “The closing...